Online Edition
The online edition of the King® Guide to Parenteral Admixtures® provides the most complete and up-to-date full text IV compatibility and stability monographs available and is the only IV compatibility reference available that has been updated quarterly since 1971.
Complete full text monographs report compatibility and stability for over 600 intravenous drugs. Each monograph reports the routes, dosages, temperatures, and containers used to determine compatibility and stability from fully referenced peer-reviewed primary sources.
Features
- Exceeds TCJ Requirements
- NABP Endorsed
- Over 600 IV drugs with at-a-glance view of compatibility in 12 fluids
- Over 3,500 Primary Source References
- Includes routes, dosages, temperatures, and containers used to determine compatibility and stability.
- Y-Site, Syringe, and other sets/container specific information.
- Extensive TPN/TNA data.
- Special Sections on Stability and Storage
- Boxed Warning and Hazardous Drugs List and Identification
- Proprietary and Generic Drug Names Included
Winter 2026
In this update, we added a new drug monograph for RITUXIMAB-arrx.
In addition, we included new stability information in the monographs for DOXORUBICIN HYDROCHLORIDE, KETAMINE HYDROCHLORIDE, and MEROPENEM.
Compatibility information was added to these monographs: CEFOTAXIME SODIUM, DEXMEDETOMIDINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, FENTANYL CITRATE, KETAMINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE, MORPHINE SULFATE, PIPERACILLIN AND TAZOBACTAM, VANCOMYCIN HYDROCHLORIDE, and AMOXICILLIN-CLAVULANATE with 21 other drugs.
